SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-019516
Filing Date
2022-05-11
Accepted
2022-05-11 16:03:23
Documents
16
Period of Report
2022-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20220511.htm   iXBRL 8-K 35494
2 PRESS RELEASE EARNINGS acor-ex991_15.htm EX-99.1 316270
3 PRESS RELEASE BIOPAS acor-ex992_16.htm EX-99.2 16627
4 GRAPHIC gzjlu4vqazy1000001.jpg GRAPHIC 4764
5 GRAPHIC gopgsajknide000001.jpg GRAPHIC 4764
  Complete submission text file 0001564590-22-019516.txt   530086

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acor-20220511.xsd EX-101.SCH 5581
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20220511_lab.xml EX-101.LAB 18589
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20220511_pre.xml EX-101.PRE 11029
10 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20220511_htm.xml XML 3422
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 22913623
SIC: 2836 Biological Products, (No Diagnostic Substances)